Myocardin-related transcription factor A cooperates with brahmarelated gene 1 to activateP-selectin transcription

Mingzi Song,Mingming Fang,Liming Yu,Yong Xu

1Departments of Pathophysiology and Nursing,Jiangsu Jiankang Vocational University,Nanjing,Jiangsu 210029,China;

2Key Laboratory of Cardiovascular Disease,Department of Pathophysiology,Nanjing Medical University,Nanjing,Jiangsu 210029,China.

Myocardin-related transcription factor A cooperates with brahmarelated gene 1 to activateP-selectin transcription

Mingzi Song1,△,Mingming Fang1,2,△,?,Liming Yu1,Yong Xu2,?

1Departments of Pathophysiology and Nursing,Jiangsu Jiankang Vocational University,Nanjing,Jiangsu 210029,China;

2Key Laboratory of Cardiovascular Disease,Department of Pathophysiology,Nanjing Medical University,Nanjing,Jiangsu 210029,China.

Expression of P-selectin in injured or activated endothelia cells serves as a permissive step towards leukocyte recruitment and perpetuation of inflammation in the pathogenesis of atherosclerosis.P-selectin can be induced by pro-inflammatory stimuli via the transcription factor NF-κB,but the epigenetic mechanisms remain incompletely understood.Previously we reported that myocardin-related transcription factor A(MRTF-A)mediates the transactivation of a slew of adhesion molecules by oxidized low-density lipoprotein(oxLDL),likely through a crosstalk with brahma-related gene 1(BRG1),a chromatin remodeling protein.Here,we show that MRTF-A was both sufficient and necessary for the transactivation of P-selectin gene in endothelial cells treated with TNF-α.Depletion of MRTF-A using small interfering RNA(siRNA)abrogated the binding of BRG1 on the P-selectin promoter.Overexpression of BRG1 up-regulated the activity of P-selectin promoter activity while BRG1 knockdown attenuated P-selectin expression.Finally,BRG1 silencing suppressed the accumulation of acetylated histone H3 and methylated histone H3K4,and altered the binding of NF-κB on the P-selectin promoter.Therefore,our data demonstrate an essential role for MRTF-A and BRG1 in P-selectin transactivation in endothelial cells.

myocardin-related transcription factor A(MRTF-A),brahma-related gene 1(BRG1),P-selectin, endothelial cell

Introduction

Under physiological conditions,the endothelial layer of the vessels does not support a firm interaction with circulating leukocytes.In response to various injurious signals,expression of adhesion molecules by endothelial cells allows attraction,retention,and trans-membrane migration of leukocytes,thereby initiating vascular inflammation[1].This pathophysiological process constitutes a pivotal step in the pathogenesis of a host of cardiovascular diseases including atherosclerosis[2],pulmonary hypertension[3],and myocardial infarction[4].

Adhesion of leukocytes to the vessel wall is mediated by a group of structurally and functionally diverse membrane proteins called adhesion molecules[5].This family of proteins includes intercellular adhesion molecules(ICAMs), vascular adhesion molecules(VCAMs),and selectins. Previous studies indicated that each adhesion molecule preferentially mediates the adhesion of a sub-set of circulating leukocytes to the vessel wall.For instance,P-selectin isknown to specifically support the adhesion of platelets while ICAM-1 is necessary for the adhesion of lymphocytes[6-7].While the basal expression level of P-selectin is low in endothelial cells,its transcription rate can be rapidly turned on by a number of pro-inflammatory factors including tumor necrosis factor(TNF-α),lipopolysaccharide (LPS),and hypoxia.

Myocardin-related transcription factor A,or MRTF-A, was first identified as a co-factor for serum response factor (SRF)to promote the transcription of muscle-specific genes[8].MRTF-A deficiency in mice does not disturb organogenesis,but seems to protect the rodents from atherosclerosis[9],pulmonary hypertension[10],and myocardial infarction[11].In addition,in vitro studies conducted in cultured endothelial cells demonstrate that MRTF-A is required for the transactivation of ICAM-1,VCAM-1, and E-selectin genes[12].We report here that MRTF-A is also responsible for P-selectin transactivation in TNF-α treated endothelial cells by recruiting the chromatin remodeling protein BRG1 to alter the chromatin structure.

Materials and methods

Cell culture and treatment

Human immortalized umbilical vein endothelial cells(EAhy926,ATCC,Manassas,VA,USA)were maintained in Dulbecco's modified Eagle's medium (DMEM,Invitrogen,Carlsbad,CA,USA)supplemented with 10%fetal bovine serum(FBS,Hyclone).Prior to treatment,cells were serum starved overnight and then treated with TNF-α(R&D,Minneapolis,MN,USA).

Plasmids,transient transfection,and reporter assay

FLAG-tagged MRTF-A construct,FLAG-tagged BRG1construct,P-selectin promoter-luciferase construct (-1379/-13),short hairpin RNA(shRNA)construct for MRTF-A,small interfering RNA(siRNA)sequences for human MRTF-A and BRG1 have been previously described[12-15].Transient transfections were performed with Lipofectamine 2000(Invitrogen).Luciferase activities were assayed 24-48 hours after transfection using a luciferase reporter assay system(Promega,Madison, WI,USA).Experiments were routinely performed in triplicate wells and repeated three times.

Protein extraction and Western blotting assays

Whole cell lysates were obtained by re-suspending cell pellets in RIPA buffer(50 mmol/L Tris pH7.4, 150 mmol/L NaCl,1%Triton X-100)with freshly added protease inhibitors(Roche,Burgess Hill,west Sussex,UK).Western blot analyses were performed with anti-MRTF-A,anti-BRG1(Santa Cruz Biotechnology,Santa Cruz,CA,USA),and anti-β-actin (Sigma,St.Louis,MO,USA)antibodies.

RNA isolation and real-time PCR

RNA was extracted with the RNeasy RNA isolation kit (Qiagen).Reverse transcriptase reactions were performed using a SuperScript First-strand Synthesis System (Invitrogen).Real-time PCR was performed on an ABI Prism 7500 system.Primers and Taqman probes,used for real-time reactions,were purchased from Applied Biosystems.

Chromatin Immunoprecipitation(ChIP)

Chromatin Immunoprecipitation(ChIP)assays were performed essentially as described before[16].In brief, chromatin in control and treated cells were cross-linked with1%formaldehyde.Cells were incubated in lysis buffer(150mmol/LNaCl,25mmol/LTrispH7.5,1%Triton X-100,0.1%SDS,0.5%deoxycholate)supplemented with a protease inhibitor tablet and PMSF.DNA was fragmented into～500 bp pieces using a Branson 250 sonicator.Aliquots of lysates containing200μg of protein were used for each immunoprecipitation reaction with anti-MRTF-A,anti-BRG1,anti-NF-κB/p65(Santa Cruz Biotechnology),anti-acetyl histone H3,and antitrimethy lated histone H3K4(Millipore,Billerica,MA, USA).Precipitated genomic DNA was amplified by real-time PCR using previously described primers[17].

Statistical analysis

One-way ANOVA with post-hoc Scheffe analyses were performed using an SPSS package.P values smaller than.05 were considered statistically significant.

Results

MRTF-A activatesP-selectin transcription in endothelial cells

We have previously shown that MRTF-A mediates the transactivation of ICAM-1,VCAM-1,and E-selectin genes in endothelial cells in response to the stimulation of oxLDL[12]and hypoxia[10].Since P-selectin is also involved in the interaction between vascular endothelium and circulating leukocytes,we hypothesized that MRTF-A might activate P-selectin transcription.We transfected a P-selectin promoter- luciferase fusion construct into EAhy926 cells with or without an MRTF-A expression construct.As shown inFig.1A,MRTF-A up-regulated P-selectin promoter activity in adose-dependent manner.In addition,MRTF-A markedly enhanced the activation of the P-selectin promoter by TNF-α (Fig.1B).On the contrary,knockdown of MRTF-Aexpression by a shRNA plasmid attenuated TNF-α induced activation of the P-selectin promoter(Fig. 1C).Therefore,MRTF-A can indeed activate P-selectin transcription in endothelial cells.

Fig.1MRTF-A is essential for the transactivation of P-selectin promoter by TNF-ain endothelial cells.A：A P-selectin promoter construct was transfected into EAhy926 with increasing amounts of MRTF-A expression construct.Luciferase activities were normalized to the control group and expressed as relative luciferase unit(RLU).B：A P-selectin promoter construct was transfected into EAhy926 with or without MRTF-A followed by treatment with TNF-α.Luciferase activities were normalized to the control group and expressed as RLU.C：A P-selectin promoter construct was transfected into EAhy926 with shRNA plasmid targeting MRTF-A(shMRTF-A)or a control shRNA plasmid(non-target)followed by treatment with TNF-α.Luciferase activities were normalized to the control group and expressed as RLU.

Fig.2MRTF-A is essential for BRG1 recruitment.A：EAhy926 cells were transfected with siRNA targeting MRTF-A or scrambled siRNA (SCR)followed by treatment with TNF-α.The mRNA transcript levels of P-selectin were measured by qPCR.Knockdown efficiency of MRTF-A siRNA was verified by qPCR and Western blotting.B：EAhy926 cells were transfected with siRNA targeting MRTF-A,or scrambled siRNA(SCR), followed by treatment with TNF-α.ChIP assays were performed with anti-MRTF-A or anti-BRG1.Precipitated DNA was amplified by primers flanking the P-selectin gene proximal promoter.

MRTF-A is essential for BRG1 recruitment

Next,we asked whether MRTF-A might be essential for the induction of endogenous P-selectin messages by TNF-α in endothelial cells.We used siRNA to deplete endogenous MRTF-A;MRTF-A depletion downregulated P-selectin induction by more than 50%in the presence of TNF-α(Fig.2A).Furthermore,TNF-α stimulated the occupancy of MRTF-A on the P-selectin promoter(Fig.2B).Therefore,MRTF-A may be an activator of P-selectin transcription by directly binding to the P-selectin promoter.

Prior studies have demonstrated that the chromatin remodeling protein BRG1 is required for MRTF-A dependent transcription in vascular smooth muscle cells[18],macrophages[19],and endothelial cells[20].BRG1 binding on the P-selectin promoter was up-regulated by TNF-α;depletion of MRTF-A with siRNA simultaneously blocked the binding of MRTF-A and BRG1 to the P-selectin promoter(Fig.2B).Collectively,these data suggest that MRTF-A might recruit BRG1 to activate P-selectin transcription.

BRG1 contributes toP-selectin transactivation

To verify the functional interaction between MRTF-A and BRG1 in transactivating the P-selectin gene,we performed the following reporter assays.Co-expression of wild type(WT),but not an enzyme deficient(ED),form of BRG1 with MRTF-A additively activated the P-selectin promoter(Fig.3A).On the other hand,siR NA-mediated depletion of BRG1ameliorated MRTF-A-induced P-select in promoter activation(Fig.3B).Similarly,BRG1 WT instead of BRG1 ED enhanced activation of P-selectin promoter by TNF-α(Fig.3C).Finally,BRG1 silencing suppressed P-selectin promoter activation by TNF-α(Fig. 3D).Together,these data suggest that BRG1 might be an integral part of TNF-α-induced,MRTF-A-mediated P-selectin transactivation.

BRG1 alters the chromatin structure surrounding P-selectin promoter

We then tackled the mechanism whereby BRG1 might contribute to P-selectin transactivation.Asshown inFig.4A,BRG1 depletion by siRNA down-regulated the induction of endogenous P-selectin mRNA transcripts by TNF-α.BRG1 siRNA also prevented the binding of BRG1 to the P-selectin promoter(Fig.4B).In the meantime,BRG1 silencing eliminated the enrichment of two preeminent histone markers indicative of transcriptionalactivation,namely acetylated histone H3 and trimethylated histone H3K4,on the P-selectin promoter.

Fig.3BRG1 is essential for the transactivation of P-selectin promoter by TNF-ain endothelial cells.A：A P-selectin promoter construct was transfected into EAhy926 with MRTF-A,wild type(WT) BRG1,or enzyme deficient(ED)BRG1.Luciferase activities were normalized to the control group and expressed as relative luciferase unit (RLU).B：A P-selectin promoter construct was transfected into EAhy926 with MRTF-A,siRNA targeting BRG1,or SCR.Luciferase activities were normalized to the control group and expressed as RLU.C：A P-selectin promoter construct was transfected into EAhy926 with WT BRG1 or ED BRG1 followed by treatment with TNF-α.Luciferase activities were normalized to the control group and expressed as RLU.D：A P-selectin promoter construct was transfected into EAhy926 with siRNA targeting BRG1 or SCR followed by treatment with TNF-α.Luciferase activities were normalized to the control group and expressed as RLU.

The sequence-specific transcription factor NF-κB/p65 has been shown to mediate TNF-α induced P-selectin transcription[21].Indeed,TNF-α stimulation promoted the binding of p65 on the P-selectin promoter in EAhy926 cells in a time course-dependent manner：significant p65 binding started to appear on the P-selectin promoter as early as three hours post-treatment,peaked at six hours and declined at nine hours(Fig.4C).BRG1 depletion, however,impairedp65binding;withoutBRG1,p65binding peaked less and declined more(Fig.4C).Combined, these data suggest that BRG1 might regulate P-selectintranscription by altering histone modification and p65 binding kinetics on the P-selectin promoter.

Fig.4BRG1 modulates histone modification and NF-kB binding on theP-selectinpromoter.A：EAhy926 cells were transfected with siRNA targeting BRG1 or SCR followed by treatment with TNF-α.The mRNA transcript levels of P-selectin were measured by qPCR.Knockdown efficiency of BRG1 siRNA was verified by qPCR and Western blotting.B：EAhy926 cells were transfected with siRNA targeting BRG1 or SCR followed by treatment with TNF-α.ChIP assays were performed with anti-BRG1,anti-acetyl histone H3(AcH3),and anti-methylated histone H3K4 (H3K4Me3).C：EAhy926 cells were transfected with siRNA targeting BRG1 or SCR followed by treatment with TNF-α.ChIP assays were performed with anti-BRG1 and anti-p65.

Discussion

We show evidence here that MRTF-A and BRG1 cooperate to activate P-selectin transcription in vascular endothelial cells.In light of our previous findings that suggest MRTF-A can activate the transcription of other adhesion molecules[10,12],these new data allude to the possibility that targeting MRTF-A in endothelial cells could alleviate leukocyte adhesion and thus vascular inflammation in human diseases[22].

Our data suggest that MRTF-A activates P-selectin gene in endothelial cells.It is known that P-selectin expression is detected in platelets and that P-selectin is required for platelet function[23];one wonders whether MRTF-A might also drive P-selectin expression in platelets. Indeed,Krause and colleagues have recently shown thatMRTF-A,along with its family member MRTF-B,play essential roles in megakaryocyte maturation and platelet formation,acting as a co-factor for SRF[24].It would be of great interest to determine whether the deficiency in platelet formation in MRTF-A/B-null mice can be rescued by the introduction of exogenous P-selectin.

Mounting evidence has made it abundantly clear that MRTF-A may act as a bridge between the epigenetic machinery and the basal transcription machinery[14,18,20,25-28].We show here that MRTF-A activates P-selectin by recruiting BRG1 to the promoter region. BRG1 can sense a number of pro-inflammatory stimuli,including LPS[29],hypoxia[30],nutrition excess[31], and TNF-α[13],to program cellular response.Of note, BRG1 is absolutely required for vasculogenesis,as germ line deletion of systemic BRG1 or endothelial BRG1 in mice causes lethality due to extensive defects of the vasculature[32].On the other hand,adult mice with induced deletion of BRG1 in endothelial cells appear to be normal under physiological conditions[33]. Based on the current dataset,we speculate that mice with inducible deletion of endothelial BRG1 would be protected from inflammation-associated adverse cardiovascular episodes,likely as a consequence of dampened synthesis of adhesion molecules including P-selectin.This hypothesis should be tested in future studies to further validate the role of BRG1 in vivo.

Consistent with our previous findings that BRG1 could forge a crosstalk with histone modifying enzymes[13,20,25,31], we demonstrate here that BRG1 depletion led to the disappearance of acetylated histone H3 and methylated histone H3K4from the P-selectin promoter.ChIP-sequencing analyses have indicated a co-enrichmen to fBRG1,AcH3,and H3K4Me3 in a cell-specific and differentiation-dependent manner[34-35].It remains to be determined howBRG1 modulates histone modification on a genome-wide scale in inflammation-challenged endothelial cells.Another interesting finding in the present study is that BRG1deficiency altered the binding of p65,although it is not clear whether this is due to BRG1-dependent nucleosome displacement or changes in histone modifications or both.Ding et al.recently found that vitamin D receptor (VDR)binding deprives certain regions of the chromatin of acetylated histones.This renders them less permissible for SMAD3 to bind,which explains the anti-fibrogenic effect of VDR[36].BRG1 might operate in a similar mode to modulate p65 binding.

In summary,we report here an epigenetic mechanism by which MRTF-A regulates P-selectin transcription. Future investigations employing spatiotemporally controlled animal models and ChIP-seq analysis would shed more light on the role of MRTF-A in regulating the vascular transcriptome.

Acknowledgements

This work was supported by the Natural Science Foundation of Jiangsu Province(BK20141498)and a grant from Jiangsu Jiankang Vocational University (JKC201505).Y.X.is a Fellow at the Collaborative Innovative Center for Cardiovascular Translational Medicine.

References

[1]Barreiro O,Martin P,Gonzalez-Amaro R,et al.Molecular cues guiding inflammatory responses[J].Cardiovas Res, 2010,86(2)：174-182.

[2]Cybulsky MI,Gimbrone MA,Jr.Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis[J].Science,1991,251(4995)：788-791.

[3]Stenmark KR,Fagan KA,Frid MG.Hypoxia-induced pulmonary vascular remodeling：cellular and molecular mechanisms[J].Circ Res,2006,99(7)：675-691.

[4]Frangogiannis NG,Smith CW,Entman ML.The inflammatory response in myocardial infarction[J].Cardiovas Res, 2002,53(1)：31-47.

[5]He P.Leucocyte/endothelium interactions and microvessel permeability：coupled or uncoupled[J]?Cardiovas Res,2010,87(2)：281-290.

[6]Cambien B,Wagner DD.A new role in hemostasis for the adhesionreceptorP-selectin[J].TrendsMolMed,2004,10(4)：179-186.

[7]Long EO.ICAM-1：getting a grip on leukocyte adhesion[J]. J Immunol,2011,186(9)：5021-5023.

[8]Wang DZ,Li S,Hockemeyer D,et al.Potentiation of serum response factor activity by a family of myocardin- related transcription factors[J].P Natl Acad Sci USA,2002,99(23)：14855-14860.

[9]Minami T,Kuwahara K,Nakagawa Y,et al.Reciprocal expression of MRTF-A and myocardin is crucial for pathological vascular remodelling in mice[J].EMBO J,2012, 31(23)：4428-4440.

[10]ChenD,YangY,ChengX,etal.Megakaryocy ticleukemia 1 directs a histone H3lysine4methyl transferase complexto regulate hypoxic pulmonary hypertension[J].Hypertension,2015,65(4)：821-833.

[11]Small EM,Thatcher JE,Sutherland LB,et al.Myocardinrelated transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction[J]. Circ res,2010,107(2)：294-304.

[12]Fang F,Yang Y,Yuan Z,et al.Myocardin-related transcription factor A mediates OxLDL-induced endothelial injury[J].Circ Res,2011,108(7)：797-807.

[13]Fang F,Chen D,Yu L,et al.Proinflammatory stimuli engage brahma related gene 1 and brahma in endothelial injury[J].Circ Res,2013,113(8)：986-996.

[14]Yang Y,Chen D,Yuan Z,et al.Megakaryocytic leukemia 1(MKL1)ties the epigenetic machinery to hypoxiainduced transactivation of endothelin-1[J].Nucleic Acids Res,2013,41(12)：6005-6017.

[15]Pan J,McEver RP.Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family[J].J Biol Chem,1995,270(39)：23077-23083.

[16]Fang M,Kong X,Li P,Fang F,Wu X,Bai H,et al.RFXB and its splice variant RFXBSV mediate the antagonism between IFNgamma and TGFbeta on COL1A2 transcription in vascular smooth muscle cells[J].Nucleic Acids Res,2009,37(13)：4393-4406.

[17]Li P,Zhao Y,Wu X,et al.Interferon gamma(IFN-gamma)disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription[J].Nucleic Acids Res,2012,40(4)：1609-1620.

[18]Zhou J,Zhang M,Fang H,et al.The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression[J].Arterioscl Throm Vas, 2009,29(6)：921-928.

[19]Yu L,Weng X,Liang P,et al.MRTF-A mediates LPS-induced pro-inflammatory transcription by interacting with the COMPASS complex[J].J Cell Sci,2014,127(21)：4645-4657.

[20]Weng X,Yu L,Liang P,et al.A crosstalk between chromatin remodeling and histone H3K4 methyl transferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy[J].J Mol Cell Card,2015,82：48-58.

[21]Pan J,Xia L,Yao L,et al.Tumor necrosis factor-alpha-or lipopolysaccharide-induced expression of the murine P-selectin gene in endothelial cells involves novel kappaB sites and a variant activating transcription factor/cAMP response element[J].J Biol Chem,1998,273(16)：10068-10077.

[22]Totani L,Evangelista V.Platelet-leukocyte interactions in cardiovascular disease and beyond[J].Arterioscl Throm Vas,2010,30(12)：2357-2361.

[23]McEverRP.Selectins：initiators of leucocyte adhesion and signalling at the vascular wall[J].Cardiovas Res,2015.

[24]SmithEC,ThonJN,DevineMT,etal.MKL1andMKL2play redundant and crucial roles in megakaryocyte maturation and platelet formation[J].Blood,2012,120(11)：2317-2329.

[25]Yang Y,Cheng X,Tian W,et al.MRTF-A steers an epigenetic complex to activate endothelin -induced proinflammatory transcription in vascular smooth muscle cells[J].Nucleic Acids Res,2014,42(16)：10460-10472.

[26]Weng X,Yu L,Liang P,et al.Endothelial MRTF-A mediates angiotensin II induced cardiac hypertrophy[J].J Mol Cell Card,2015,80(1)：23-33.

[27]Lockman K,Taylor JM,Mack CP.The histone demethylase,Jmjd1a,interacts with the myocardin factors to regulate SMC differentiation marker gene expression[J]. Circ Res,2007,101(12)：e115-e123.

[28]Xu H,Wu X,Qin H,et al.Myocardin-Related Transcription Factor A Epigenetically Regulates Renal Fibrosis in Diabetic Nephropathy[J].J Am Soc Nephrol,2014.

[29]Ramirez-Carrozzi VR,Nazarian AA,Li CC,et al.Selective and antagonistic functions of SWI/SNF and Mi-2beta nucleosome remodeling complexes during an inflammatory response[J].Gene Dev,2006,20(3)：282-296.

[30]ChenD,FangF,YangY,etal.Brahma-relatedgene1(Brg1) epigenetically regulates CAM activation during hypoxic pulmonary hypertension[J].Cardiovas Res,2013,100(3)：363-373.

[31]Tian W,Xu H,Fang F,et al.Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice[J].Hepatology, 2013,58(2)：576-588.

[32]Griffin CT,Brennan J,Magnuson T.The chromatinremodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development[J]. Development,2008,135(3)：493-500.

[33]Willis MS,Homeister JW,Rosson GB,et al.Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart[J].Circ Res, 2012,111(5)：e111-e122.

[34]Yu Y,Chen Y,Kim B,et al.Olig2 targets chromatin remodelers to enhancers to initiate oligodendrocyte differentiation[J].Cell,2013,152(1-2)：248-261.

[35]Rada-Iglesias A,Bajpai R,Swigut T,et al.A unique chromatin signature uncovers early developmental enhancers in humans[J].Nature,2011,470(7333)：279-283.

[36]Ding N,Yu RT,Subramaniam N,et al.A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response[J].Cell,2013,153(3)：601-613.

△These authors contributed equally to this work.

?Mingming Fang,M.D.Jiangsu Jiankang Vocational University,Nanjing,Jiangsu 210029,China.Tel：86862107, Fax：86862888,E-mail：dafeifang@163.com;Yong Xu,Ph.D.Nanjing Medical University,Nanjing,Jiangsu210029,China.Tel：+86-25-86862888,

Fax：+86-25-86862888,E-mail：yjxu@njmu.edu.cn.

25 May 2015,Revised 31 July 2015,Accepted 26 August 2015, Epub 20 September 2015

R541.4,Document code：A

The authors reported no conflict of interests.